NOVARTIS AG

NOVN
Delayed Quote. Delayed  - 09/23 05:40:22 am
81.69CHF +0.02%
Prev.81.6700
Open81.1000
High81.8000
Low80.6100
Volume1 659 461
Latest news
2h ago
1d ago
1d ago
4d ago
Chart NOVARTIS AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance83,188,095,6
Spread/Res.-1,7%-7,2%-15%
Spread/Supp.1,4%8,2%15%
Support80,575,571,0
Financials
Sales 2020 49 760 M - -
Net income 2020 8 955 M - -
Net Debt 2020 18 049 M - -
P/E ratio 2020 22,1x
Yield 2020 3,56%
Capitalization 196 B 196 B -
EV / Sales 2020 4,29x
EV / Sales 2021 3,95x
Nbr of Employees 110 000
Free-Float 86,9%
Company
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (79.5%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2020-10-27 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 107,09 $
Last Close Price 88,76 $
Spread / Highest target 46,0%
Spread / Average Target 20,6%
Spread / Lowest Target -8,24%